Lisata Therapeutics (LSTA)

• Market cap: $9.55M
• 1 day: -0.93%
• 5 days: 7.07%
• 1 month: -67.58%
• 3 months: -67.18%
• 6 months: -76.7%
• Year to date: -45.92%
• 1 year: -62.14%
• 5 years: -94.65%
• 10 years: -98.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Employees: 21